{"id":326318,"date":"2022-10-11T11:16:04","date_gmt":"2022-10-11T11:16:04","guid":{"rendered":"https:\/\/egy-africa.com\/en\/?p=326318"},"modified":"2022-10-11T11:16:04","modified_gmt":"2022-10-11T11:16:04","slug":"bayer-to-invest-egp-240-m-in-a-drug-production-hub-in-egypt","status":"publish","type":"post","link":"https:\/\/egy-africa.com\/en\/2022\/10\/11\/bayer-to-invest-egp-240-m-in-a-drug-production-hub-in-egypt\/","title":{"rendered":"Bayer to invest EGP 240 m in a drug production hub in Egypt"},"content":{"rendered":"<p class=\"p1\"><span class=\"s1\">Bayer \u2014 a global life science company \u2014 is celebrating the announcement of its partnership with an Egyptian pharmaceutical company to establish a drug production hub for over the counter (OTC) products under the auspices of the Egyptian Drug Authority (EDA). <\/span><\/p>\n<p class=\"p1\"><span class=\"s1\">Bayer announced its three-year strategy to expand its business within the Egyptian market by producing 60 to 70% of its OTC drugs for consumers locally and will re-launch five new consumer health-related products by the end of 2025. <\/span><\/p>\n<p class=\"p1\"><span class=\"s1\">This comes in line with Egypt\u2019s 2030 Vision and the company\u2019s vision of \u2018Health for All, Hunger for None.\u2019\u00a0<\/span><\/p>\n<p class=\"p1\"><span class=\"s1\">The announcement was shared during a launch event on Monday that was attended by both parties and their senior staff, including Tamer Mohamed Essam, Chairperson of the EDA, and Mohamed Galal \u2014 Vice President and Head of Bayer Consumer Health Division in the Middle East \u2014 along with a list of key opinion leaders in the industry and media representatives.\u00a0<\/span><\/p>\n<p class=\"p1\"><span class=\"s1\">Under the auspices of the EDA, this collaboration aims to offer patients in Egypt access to the latest innovations in the field of consumer health. Furthermore, it is an exemplary model for the reforms the Egyptian government is promoting in the healthcare sector by having well-known pharmaceutical companies enter into partnerships and joint ventures that are aligned with the country\u2019s 2030 Vision.\u00a0<\/span><\/p>\n<p class=\"p1\"><span class=\"s1\">Bayer is a life science company and a global health care and nutrition leader. The group\u2019s vision is to deliver world-class innovation, drive operational performance, and generate sustainable impact by serving the most basic human needs \u2014 health and food \u2014 through its three main divisions: Crop Science, Pharmaceuticals, and Consumer Health.<\/span><\/p>\n<p class=\"p1\"><span class=\"s1\">During the celebration, Essam highlighted the importance of this step with Bayer and said: \u201cThe role of the EDA is to support the policy of drug localisation to reduce the possibility of drug shortages in the local market, in addition to encouraging investments in Egypt.\u201d <\/span><\/p>\n<p class=\"p1\"><span class=\"s1\">He added that the EDA has reformed its policies to promote localisation efforts by providing flexible regulations for licensing drugs and fast-track clearance for new products and will continue to offer the manufacturer all available technical assistance to facilitate the registration and launch of all the drugs that are intended to be made locally.<\/span><\/p>\n<p class=\"p1\"><span class=\"s1\">On behalf of Bayer, Galal acknowledged that \u201cEgypt has established itself as one of the fastest-growing markets in the Middle East. The industrial sector is an important pillar in the Egyptian government\u2019s economic reform plan and represents a valuable contribution to the achievement of Egypt\u2019s 2030 Vision for Sustainable Development.\u201d<\/span><\/p>\n<p class=\"p1\"><span class=\"s1\">\u201cIn this context, Bayer\u2019s plans on investing EGP 240m in the Egyptian market to re-launch five new products to the local market, in addition to the current locally manufactured products.\u201d<\/span><\/p>\n<p class=\"p1\"><span class=\"s1\">\u201cOur underlying three-year strategy is to expand its business within the Egyptian market by producing 60 to 70% of its OTC drugs for consumers locally by the end of 2025,\u201d he added.<\/span><\/p>\n<p class=\"p2\"><span class=\"s1\">Ahmed Farrag \u2014 Commercial Lead in Egypt and the Levant at Bayer\u2019s Consumer Health Division \u2014 added: \u201cThe establishment of a local drug production hub in Egypt reflects the strategic importance of the Egyptian market for Bayer. This will bring us one step closer to our consumers and enable us to ensure the availability of our renowned and iconic brands to Egyptian consumers, while also responding to logistical challenges following the pandemic.\u201d<\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Bayer \u2014 a global life science company \u2014 is celebrating the announcement of its partnership with an Egyptian pharmaceutical company to establish a drug production hub for over the counter (OTC) products under the auspices of the Egyptian Drug Authority (EDA).<\/p>\n","protected":false},"author":2,"featured_media":326319,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[26],"tags":[],"class_list":["post-326318","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-invest"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.3 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Bayer to invest EGP 240 m in a drug production hub in Egypt - egy-africa<\/title>\n<meta name=\"description\" content=\"Bayer \u2014 a global life science company \u2014 is celebrating the announcement of its partnership with an Egyptian pharmaceutical company to establish a drug production hub for over the counter (OTC) products under the auspices of the Egyptian Drug Authority (EDA).\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/egy-africa.com\/en\/2022\/10\/11\/bayer-to-invest-egp-240-m-in-a-drug-production-hub-in-egypt\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Bayer to invest EGP 240 m in a drug production hub in Egypt - egy-africa\" \/>\n<meta property=\"og:description\" content=\"Bayer \u2014 a global life science company \u2014 is celebrating the announcement of its partnership with an Egyptian pharmaceutical company to establish a drug production hub for over the counter (OTC) products under the auspices of the Egyptian Drug Authority (EDA).\" \/>\n<meta property=\"og:url\" content=\"https:\/\/egy-africa.com\/en\/2022\/10\/11\/bayer-to-invest-egp-240-m-in-a-drug-production-hub-in-egypt\/\" \/>\n<meta property=\"og:site_name\" content=\"egy-africa\" \/>\n<meta property=\"article:published_time\" content=\"2022-10-11T11:16:04+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/i0.wp.com\/egy-africa.com\/en\/wp-content\/uploads\/2022\/10\/WhatsApp_Image_2022-10-09_at_6.14.57_PM-768x430-1.jpeg?fit=768%2C430&ssl=1\" \/>\n\t<meta property=\"og:image:width\" content=\"768\" \/>\n\t<meta property=\"og:image:height\" content=\"430\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"FGY TEAM\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"FGY TEAM\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/egy-africa.com\/en\/2022\/10\/11\/bayer-to-invest-egp-240-m-in-a-drug-production-hub-in-egypt\/\",\"url\":\"https:\/\/egy-africa.com\/en\/2022\/10\/11\/bayer-to-invest-egp-240-m-in-a-drug-production-hub-in-egypt\/\",\"name\":\"Bayer to invest EGP 240 m in a drug production hub in Egypt - egy-africa\",\"isPartOf\":{\"@id\":\"https:\/\/egy-africa.com\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/egy-africa.com\/en\/2022\/10\/11\/bayer-to-invest-egp-240-m-in-a-drug-production-hub-in-egypt\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/egy-africa.com\/en\/2022\/10\/11\/bayer-to-invest-egp-240-m-in-a-drug-production-hub-in-egypt\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/i0.wp.com\/egy-africa.com\/en\/wp-content\/uploads\/2022\/10\/WhatsApp_Image_2022-10-09_at_6.14.57_PM-768x430-1.jpeg?fit=768%2C430&ssl=1\",\"datePublished\":\"2022-10-11T11:16:04+00:00\",\"dateModified\":\"2022-10-11T11:16:04+00:00\",\"author\":{\"@id\":\"https:\/\/egy-africa.com\/en\/#\/schema\/person\/766449568f62e1fb3bb25b041186d203\"},\"description\":\"Bayer \u2014 a global life science company \u2014 is celebrating the announcement of its partnership with an Egyptian pharmaceutical company to establish a drug production hub for over the counter (OTC) products under the auspices of the Egyptian Drug Authority (EDA).\",\"breadcrumb\":{\"@id\":\"https:\/\/egy-africa.com\/en\/2022\/10\/11\/bayer-to-invest-egp-240-m-in-a-drug-production-hub-in-egypt\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/egy-africa.com\/en\/2022\/10\/11\/bayer-to-invest-egp-240-m-in-a-drug-production-hub-in-egypt\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/egy-africa.com\/en\/2022\/10\/11\/bayer-to-invest-egp-240-m-in-a-drug-production-hub-in-egypt\/#primaryimage\",\"url\":\"https:\/\/i0.wp.com\/egy-africa.com\/en\/wp-content\/uploads\/2022\/10\/WhatsApp_Image_2022-10-09_at_6.14.57_PM-768x430-1.jpeg?fit=768%2C430&ssl=1\",\"contentUrl\":\"https:\/\/i0.wp.com\/egy-africa.com\/en\/wp-content\/uploads\/2022\/10\/WhatsApp_Image_2022-10-09_at_6.14.57_PM-768x430-1.jpeg?fit=768%2C430&ssl=1\",\"width\":768,\"height\":430},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/egy-africa.com\/en\/2022\/10\/11\/bayer-to-invest-egp-240-m-in-a-drug-production-hub-in-egypt\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/egy-africa.com\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Bayer to invest EGP 240 m in a drug production hub in Egypt\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/egy-africa.com\/en\/#website\",\"url\":\"https:\/\/egy-africa.com\/en\/\",\"name\":\"egy-africa\",\"description\":\"Just another WordPress site\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/egy-africa.com\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/egy-africa.com\/en\/#\/schema\/person\/766449568f62e1fb3bb25b041186d203\",\"name\":\"FGY TEAM\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/egy-africa.com\/en\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/6e82bb52c7fb4184d4805af7ec868b48?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/6e82bb52c7fb4184d4805af7ec868b48?s=96&d=mm&r=g\",\"caption\":\"FGY TEAM\"},\"sameAs\":[\"mohamed nour\"],\"url\":\"https:\/\/egy-africa.com\/en\/author\/egy-team\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Bayer to invest EGP 240 m in a drug production hub in Egypt - egy-africa","description":"Bayer \u2014 a global life science company \u2014 is celebrating the announcement of its partnership with an Egyptian pharmaceutical company to establish a drug production hub for over the counter (OTC) products under the auspices of the Egyptian Drug Authority (EDA).","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/egy-africa.com\/en\/2022\/10\/11\/bayer-to-invest-egp-240-m-in-a-drug-production-hub-in-egypt\/","og_locale":"en_US","og_type":"article","og_title":"Bayer to invest EGP 240 m in a drug production hub in Egypt - egy-africa","og_description":"Bayer \u2014 a global life science company \u2014 is celebrating the announcement of its partnership with an Egyptian pharmaceutical company to establish a drug production hub for over the counter (OTC) products under the auspices of the Egyptian Drug Authority (EDA).","og_url":"https:\/\/egy-africa.com\/en\/2022\/10\/11\/bayer-to-invest-egp-240-m-in-a-drug-production-hub-in-egypt\/","og_site_name":"egy-africa","article_published_time":"2022-10-11T11:16:04+00:00","og_image":[{"width":768,"height":430,"url":"https:\/\/i0.wp.com\/egy-africa.com\/en\/wp-content\/uploads\/2022\/10\/WhatsApp_Image_2022-10-09_at_6.14.57_PM-768x430-1.jpeg?fit=768%2C430&ssl=1","type":"image\/jpeg"}],"author":"FGY TEAM","twitter_card":"summary_large_image","twitter_misc":{"Written by":"FGY TEAM","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/egy-africa.com\/en\/2022\/10\/11\/bayer-to-invest-egp-240-m-in-a-drug-production-hub-in-egypt\/","url":"https:\/\/egy-africa.com\/en\/2022\/10\/11\/bayer-to-invest-egp-240-m-in-a-drug-production-hub-in-egypt\/","name":"Bayer to invest EGP 240 m in a drug production hub in Egypt - egy-africa","isPartOf":{"@id":"https:\/\/egy-africa.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/egy-africa.com\/en\/2022\/10\/11\/bayer-to-invest-egp-240-m-in-a-drug-production-hub-in-egypt\/#primaryimage"},"image":{"@id":"https:\/\/egy-africa.com\/en\/2022\/10\/11\/bayer-to-invest-egp-240-m-in-a-drug-production-hub-in-egypt\/#primaryimage"},"thumbnailUrl":"https:\/\/i0.wp.com\/egy-africa.com\/en\/wp-content\/uploads\/2022\/10\/WhatsApp_Image_2022-10-09_at_6.14.57_PM-768x430-1.jpeg?fit=768%2C430&ssl=1","datePublished":"2022-10-11T11:16:04+00:00","dateModified":"2022-10-11T11:16:04+00:00","author":{"@id":"https:\/\/egy-africa.com\/en\/#\/schema\/person\/766449568f62e1fb3bb25b041186d203"},"description":"Bayer \u2014 a global life science company \u2014 is celebrating the announcement of its partnership with an Egyptian pharmaceutical company to establish a drug production hub for over the counter (OTC) products under the auspices of the Egyptian Drug Authority (EDA).","breadcrumb":{"@id":"https:\/\/egy-africa.com\/en\/2022\/10\/11\/bayer-to-invest-egp-240-m-in-a-drug-production-hub-in-egypt\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/egy-africa.com\/en\/2022\/10\/11\/bayer-to-invest-egp-240-m-in-a-drug-production-hub-in-egypt\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/egy-africa.com\/en\/2022\/10\/11\/bayer-to-invest-egp-240-m-in-a-drug-production-hub-in-egypt\/#primaryimage","url":"https:\/\/i0.wp.com\/egy-africa.com\/en\/wp-content\/uploads\/2022\/10\/WhatsApp_Image_2022-10-09_at_6.14.57_PM-768x430-1.jpeg?fit=768%2C430&ssl=1","contentUrl":"https:\/\/i0.wp.com\/egy-africa.com\/en\/wp-content\/uploads\/2022\/10\/WhatsApp_Image_2022-10-09_at_6.14.57_PM-768x430-1.jpeg?fit=768%2C430&ssl=1","width":768,"height":430},{"@type":"BreadcrumbList","@id":"https:\/\/egy-africa.com\/en\/2022\/10\/11\/bayer-to-invest-egp-240-m-in-a-drug-production-hub-in-egypt\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/egy-africa.com\/en\/"},{"@type":"ListItem","position":2,"name":"Bayer to invest EGP 240 m in a drug production hub in Egypt"}]},{"@type":"WebSite","@id":"https:\/\/egy-africa.com\/en\/#website","url":"https:\/\/egy-africa.com\/en\/","name":"egy-africa","description":"Just another WordPress site","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/egy-africa.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/egy-africa.com\/en\/#\/schema\/person\/766449568f62e1fb3bb25b041186d203","name":"FGY TEAM","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/egy-africa.com\/en\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/6e82bb52c7fb4184d4805af7ec868b48?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/6e82bb52c7fb4184d4805af7ec868b48?s=96&d=mm&r=g","caption":"FGY TEAM"},"sameAs":["mohamed nour"],"url":"https:\/\/egy-africa.com\/en\/author\/egy-team\/"}]}},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/i0.wp.com\/egy-africa.com\/en\/wp-content\/uploads\/2022\/10\/WhatsApp_Image_2022-10-09_at_6.14.57_PM-768x430-1.jpeg?fit=768%2C430&ssl=1","jetpack_shortlink":"https:\/\/wp.me\/pcF3XZ-1mTc","_links":{"self":[{"href":"https:\/\/egy-africa.com\/en\/wp-json\/wp\/v2\/posts\/326318","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/egy-africa.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/egy-africa.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/egy-africa.com\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/egy-africa.com\/en\/wp-json\/wp\/v2\/comments?post=326318"}],"version-history":[{"count":1,"href":"https:\/\/egy-africa.com\/en\/wp-json\/wp\/v2\/posts\/326318\/revisions"}],"predecessor-version":[{"id":326320,"href":"https:\/\/egy-africa.com\/en\/wp-json\/wp\/v2\/posts\/326318\/revisions\/326320"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/egy-africa.com\/en\/wp-json\/wp\/v2\/media\/326319"}],"wp:attachment":[{"href":"https:\/\/egy-africa.com\/en\/wp-json\/wp\/v2\/media?parent=326318"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/egy-africa.com\/en\/wp-json\/wp\/v2\/categories?post=326318"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/egy-africa.com\/en\/wp-json\/wp\/v2\/tags?post=326318"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}